Partenaires

CNRS
Logo Université de Strasbourg
Logo IREBS



Rechercher

Sur ce site

Sur le Web du CNRS


Accueil > News > Reducing side effects of chemotherapy while increasing their effectiveness: the promise of flavaglines!

Reducing side effects of chemotherapy while increasing their effectiveness: the promise of flavaglines!

9 janvier 2012

The side effects and drug resistance are the two major constraints of anticancer chemotherapy . Researchers at the Laboratory of therapeutic innovation (LIT) and the Laboratory of Biotechnology and Cell Signaling (BSC) (CNRS / Université de Strasbourg) have highlighted the properties of a family of anticancer agents, flavaglines, to significantly offset these problems in mice.

This work published in Plos One, opens up promising avenues in future treatments against cancer.

More information